-
720550-100MG
(3AR 8AR)-4 4 8 8-TETRAKIS(3 5-DI-TERT-BUTYLPHENYL)-2 2-DIETHYL-6-PHENYLTETRAHYDRO-[1 3]DIOXOLO[4 5-E][1 3 2]DIOXAPHOSPHEPINE >=94% (C005B-225623)
Price: $716.35List Price: $795.95Application Reactant for: Preparation of potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk) -
P650497-50mg
(R)-PS210 (C007B-386237)
Price: $1,521.36List Price: $1,690.41(R)-PS210, the R enantiomer of PS210 (compound 4h-eutomer), is a substrate-selective allosteric activator of PDK1 with an AC 50 value of 1.8 μM. (R)-PS210 targets to the PIF-binding pocket of PDK1. PIF: The protein kinase C-related kinase 2 -
P650497-5mg
(R)-PS210 (C007B-386238)
Price: $324.30List Price: $360.33(R)-PS210, the R enantiomer of PS210 (compound 4h-eutomer), is a substrate-selective allosteric activator of PDK1 with an AC 50 value of 1.8 μM. (R)-PS210 targets to the PIF-binding pocket of PDK1. PIF: The protein kinase C-related kinase 2 -
P656290-1ml
(R)-PS210 (C007B-386819)
Price: $356.61List Price: $396.23(R)-PS210, the R enantiomer of PS210 (compound 4h-eutomer), is a substrate-selective allosteric activator of PDK1 with an AC 50 value of 1.8 μM. (R)-PS210 targets to the PIF-binding pocket of PDK1. PIF: The protein kinase C-related kinase 2 -
19696-1
(S)-p38 MAP Kinase Inhibitor III-1 mg
Price: $319.78List Price: $355.31A methylsulfanylimidazole that inhibits p38 MAP kinase (IC<sub>50</sub> = 0.90 µM in vitro) potently blocks the release of TNF-&alpha and IL-1&beta from human peripheral blood mononuclear cells (IC<sub>50</sub>s = 0. -
19696-10
(S)-p38 MAP Kinase Inhibitor III-10 mg
Price: $2,082.12List Price: $2,313.47A methylsulfanylimidazole that inhibits p38 MAP kinase (IC<sub>50</sub> = 0.90 µM in vitro) potently blocks the release of TNF-&alpha and IL-1&beta from human peripheral blood mononuclear cells (IC<sub>50</sub>s = 0. -
19696-5
(S)-p38 MAP Kinase Inhibitor III-5 mg
Price: $1,238.34List Price: $1,375.93A methylsulfanylimidazole that inhibits p38 MAP kinase (IC<sub>50</sub> = 0.90 µM in vitro) potently blocks the release of TNF-&alpha and IL-1&beta from human peripheral blood mononuclear cells (IC<sub>50</sub>s = 0. -
19696-500
(S)-p38 MAP Kinase Inhibitor III-500 g
Price: $197.41List Price: $219.35A methylsulfanylimidazole that inhibits p38 MAP kinase (IC<sub>50</sub> = 0.90 µM in vitro) potently blocks the release of TNF-&alpha and IL-1&beta from human peripheral blood mononuclear cells (IC<sub>50</sub>s = 0. -
91112502-1VL
143B HUMAN BONE OSTEOSARCOMA TK- (C005B-236459)
Price: $1,330.35List Price: $1,478.17Cell Line Origin Human bone osteosarcoma TK- Cell Line Description Cells are thymidine kinase deficient (TK-) and resistant to BUdR.143B and HOS (Sigma Catalogue number 87070202) originated from the same host: 143B is TK- and originated indirectly -
345733-500UG
2 3 6-TRIFLUOROPHENOL 98% (C005B-257132)
Price: $750.31List Price: $833.68General description Contains mainly N-acetylneuraminic acid. GM 3 and its derivatives play important roles in immunoregulation and in biosynthesis and metabolism of higher gangliosides. -
B287641-25mg
2B-(SP) (TFA) (C007B-060933)
Price: $3,643.13List Price: $4,047.922B-(SP) TFA is a eIF2B-based substrate for glycogen synthase kinase-3 (GSK-3). 2B-(SP) TFA is readily phosphorylated by both the α and β isoforms of GSK-3. -
05-1050
4G10« PLATINUM ANTI-PHOSPHOTYROSINE ANTIBODY (MOUSE MONOCLONAL COCKTAIL IGG2B)
Price: $1,157.95List Price: $1,286.61General description The development of the anti-phosphotyrosine, clone 4G10 in 1989 was a monumental discovery for researchers. 4G10 was the first and is the best single monoclonal antibody for the detection tyrosine phosphorylation.